— Know what they know.
Not Investment Advice

ACUS OTC

Acusphere, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +0.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $49 mcap · 5M float · 0.0021% daily turnover

Income Trends

Revenue
$3M +49.7% ▲
Gross Profit
$3M +49.7% ▲
Operating Income
$53M -15.3% ▼
5Y CAGR: +21.8%
Net Income
-$54M +12.0% ▲
EPS (Diluted)
$-12.60 +43.1% ▲
EBITDA
-$45M +13.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2003FY2004FY2005FY2006FY2007
Revenue$0$2M$3M$2M$3M
YoY Growth+0.0%+0.0%+100.0%-48.1%+49.7%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$2M$3M$2M$3M
Gross Margin—100.0%100.0%100.0%100.0%
R&D Expenses$15M$26M$42M$52M$43M
SG&A Expenses$5M$7M$7M$12M$12M
Operating Expenses$20M$32M$50M$64M$55M
Operating Income$20M$30M$46M$62M$53M
Operating Margin—1774.9%1346.8%3496.9%1977.0%
Interest Expense$2M$133K$551K$2M$2M
Income Before Tax$20M$30M$46M$63M$51M
Tax Expense$2M-$468K-$2M-$1M$1M
Net Income-$22M-$30M-$45M-$61M-$54M
Net Margin—-1747.6%-1301.6%-3430.0%-2014.6%
EPS (Diluted)$-52.35$-19.20$-23.61$-22.13$-12.60
EBITDA-$18M-$29M-$42M-$52M-$45M
Shares Outstanding4187672M2M3M4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms